Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H30O6 |
Molecular Weight | 318.4058 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(O[C@]2([H])OC(C)(C)O[C@]2([H])[C@H]1OCCCCCCC)[C@H](O)CO
InChI
InChIKey=GWSUUEYOBZZHIJ-UXXRCYHCSA-N
InChI=1S/C16H30O6/c1-4-5-6-7-8-9-19-13-12(11(18)10-17)20-15-14(13)21-16(2,3)22-15/h11-15,17-18H,4-10H2,1-3H3/t11-,12-,13+,14-,15-/m1/s1
Molecular Formula | C16H30O6 |
Molecular Weight | 318.4058 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://adisinsight.springer.com/drugs/800003766
Sources: https://adisinsight.springer.com/drugs/800003766
Seprilose is a carbohydrate compound that inhibits prostaglandin E2 synthesis. Seprilose was undergoing phase II trials with Boston Life Sciences in the USA for the treatment of Rheumatic disorders, but this development was discontinued.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:38 GMT 2023
by
admin
on
Fri Dec 15 15:41:38 GMT 2023
|
Record UNII |
5764EUK72N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C344
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60818
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
C152339
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
7268
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107533
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
5764EUK72N
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
FF-29
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
SUB10486MIG
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
DTXSID90158322
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
100000084133
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY | |||
|
133692-55-4
Created by
admin on Fri Dec 15 15:41:38 GMT 2023 , Edited by admin on Fri Dec 15 15:41:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |